-
Vaccines, Blood & Biologics
AFLURIA
Proper Name: Influenza Virus Vaccine
Tradename: AFLURIA
Manufacturer: CSL Limited, License No. 1764
Indication:
- For active immunization of persons ages 6 months and older against influenza disease caused by influenza virus subtypes A and type B present in the vaccine
-
Supporting Documents
- November 10, 2009 Approval Letter - Afluria/Influenza A (H1N1) 2009 Monovalent
Active immunization against influenza for individuals 6 months through 17 of age - July 10, 2009 Approval Letter - Afluria
2009/2010 Season Formulation - July 30, 2008 Approval Letter - Afluria
2008-2009 United States formulation. - September 28, 2007 - Afluria
For active immunization of adults 18 years of age and older against influenza disease caused by influenza virus subtypes A and type B present in the vaccine. - Additional Influenza Vaccine Approved for Upcoming Influenza Season
Press Release: September 29, 2007 - Approval History, Letters, Reviews, and Related Documents - AFLURIA
-
-
Related Information
-
-
-